Akèy › Dyabèt Tip 2 › Lwizyàn › Metairie
Etid klinik pou Dyabèt Tip 2 nan Metairie, LA
5 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Metairie (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Metairie
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- Nola Care Clinical Research Center, Metairie
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- NOLA Care Clinical Research, Metairie
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Ap rekrite
- Poirot Podiatry, Metairie
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL25 etid
- Boston, MA20 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Miami, FL19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- San Diego, CA17 etid
- Atlanta, GA17 etid
- Los Angeles, CA16 etid
Lòt etid nan Metairie
- Kansè pwostat12 etid
- Kolit Ulseratif8 etid
- Kansè vejik6 etid
- Obèsite5 etid
- Maladi Crohn5 etid
- Maladi fwa steatotik4 etid
- Kansè Metastatik4 etid
- Maladi kadyovaskilè4 etid
- Kansè renn (Kasinom selil renn)4 etid
- Timò Nèwo-endokrin3 etid
- Kasinom Selil Transizyonèl (Urotelyal)3 etid
- Sipwa3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.